Prelude Therapeutics Inc Quarterly Operating Lease, Payments in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Prelude Therapeutics Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2023 to Q1 2024.
  • Prelude Therapeutics Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Prelude Therapeutics Inc annual Operating Lease, Payments for 2023 was $1.9M, a 5.56% increase from 2022.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 -$500K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $500K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.